|
Symbol
|
RMBQ5V | KZEHDU | KZJVDU | RMBAIV | PUIRCH | KZXVDU | RMAXAV | Z0AXYZ | LAAHDU | Z0B18Z | RMA09V | RMBX5V | ACMVSQ | ADAATQ | ADGWTQ | ADKOTQ | RMAY9V | RMBACV | ADXETQ | DAGBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible |
|
Sous-jacent
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | ASML Hldg. N.V. / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Bayer AG / Novo Nordisk AS (B) | Lonza Group N / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Novo Nordisk AS (B) / Roche PS / Sanofi S.A. | Eli Lilly & Co. / Novartis AG / Novo Nordisk AS (B) / Roche PS | Bayer AG / Novo Nordisk AS (B) / Sanofi S.A. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 17.09.2026 | 08.09.2026 | 12.10.2026 | 16.10.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 | 27.11.2026 | 23.09.2026 | 08.10.2026 | 14.01.2027 | 25.01.2027 | 12.02.2027 | 12.02.2027 |
| Demande | 41,200 | 41,200 | 39,150 | 53,40 | 52,23 | - | 71,80 | 102,00 | 72,70 | 104,23 | 68,20 | 66,00 | 73,73 | 70,36 | 64,72 | 70,21 | 70,30 | 98,30 | 100,83 | 101,97 |
| Offre | - | 42,200 | - | - | - | - | - | 102,90 | 73,70 | 105,13 | - | - | - | - | - | - | - | 99,10 | 101,64 | 102,79 |